Completed × Interventional × Drug-Related Side Effects and Adverse Reactions × Clear all 05-001: Treatment of Acute Lymphoblastic Leukemia in Children
Phase 3 Completed
800 enrolled 22 charts
MIZAR-002
Phase 1/2 Completed
18 enrolled
MIZAR-001
Phase 1 Completed
43 enrolled
Pharmaceutical Care for Patients Using Capecitabine
Phase NA Completed
176 enrolled
Neoadjuvant CRT Combined With Camrelizumab and Nimotuzumab for Initially Inoperable Patients With Esophageal Carcinoma
Phase 2 Completed
35 enrolled
Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma
Phase NA Completed
79 enrolled
PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment
Phase 4 Completed
200 enrolled
13-Cis
Phase 2 Completed
96 enrolled
CRC-PIPAC
Phase 2 Completed
20 enrolled
Acupuncture Prevents Chemobrain in Breast Cancer Patients
Phase NA Completed
93 enrolled
Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
Phase 3 Completed
114 enrolled
Study Comparing Conventional and Fast Track Multi-Discipline Treatment Interventions for Colorectal Cancer
Phase 3 Completed
374 enrolled
Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer
Phase 3 Completed
137 enrolled 6 charts
Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence
Phase 2 Completed
40 enrolled
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
Phase 3 Completed
344 enrolled
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase 1/2 Completed
73 enrolled
Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase 2 Completed
160 enrolled
Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
Phase 3 Completed
233 enrolled
Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors
Phase 1 Completed
10 enrolled
Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
Phase 3 Completed
243 enrolled
Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma
Phase 1 Completed
38 enrolled
Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy
Phase 2 Completed
50 enrolled
Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer
Phase 2 Completed
37 enrolled
Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles
Phase 3 Completed
210 enrolled
Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Phase 1 Completed
Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
Phase 2 Completed
Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer
Phase 2 Completed
Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer
Phase 2 Completed
Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma
Phase 2 Completed
Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase 2 Completed
34 enrolled
Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy
Phase 4 Completed
Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma
Phase 1 Completed
3 enrolled
High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer
Phase 2 Completed
30 enrolled
Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab
Phase 2 Completed
72 enrolled
Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer
Phase 3 Completed
250 enrolled
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer
Phase 3 Completed
34 enrolled 9 charts
Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma
Phase NA Completed
41 enrolled
Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma
Phase 1 Completed
18 enrolled
Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer
Phase 1/2 Completed
Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors
Phase 2 Completed
20 enrolled
N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
Phase 1 Completed
30 enrolled
EADO
Phase 3 Completed
898 enrolled
Sleep, Fatigue, and Dexamethosone in Children With Leukemia
Phase 3 Completed
134 enrolled